https://www.selleckchem.com/pr....oducts/bibo-3304-tri
l purpose as both a drug delivery carrier and a pulmonary surfactant in treating pulmonary metastasis.We previously described the development of potent μ-opioid receptor (MOR)-agonist/δ-opioid receptor (DOR)-antagonist peptidomimetic ligands as an approach toward effective analgesics with reduced side effects. In this series, a tetrahydroquinoline (THQ) or substituted phenyl is employed to link two key pharmacophore elements, a dimethyltyrosine amino acid and typically an aromatic pendant. Using new and previously rep
Like
Comment
Share
